Website profile

@Genbio

genengnews.com @genbio
All articles Clear site filter

Get the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.

  • 774articles · 180d
  • 1+ day agolatest article
  • Mar 17, 2026earliest in window
  • 97%with images
  • 312avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Science & Technology 516
  • Science & Nature 442
  • Health & Wellness 407
  • Medical 265
  • Business & Industrial 184
  • Health 163
  • STEM 148
  • Economy, Business & Finance 78
Site tags
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@genbio
genengnews.com > topics > translational-medicine > cosmo-pharma-eyes-2027-nda-for-baldness-candidate-after-positive-phase-iii-12-month-data

Cosmo Pharma Eyes 2027 NDA for Baldness Candidate After Positive Phase III 12-Month Data

4+ mon, 3+ week ago   (623+ words) Clascoterone 5% topical solution shows 239% improvement in Target Area Hair Count in patients who remained on continuous treatment for the full length of the pivotal studies Cosmo Pharmaceuticals says it plans to file for FDA approval of its androgenetic alopecia (AGA)…...